M

MabPlex International Co., Ltd.

25 employees

MabPlex provides CDMO services in the development and manufacturing of biopharmaceuticals.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Monoclonal Antibody Therapeutics
Association
Contract Research
Non Profit
Antibody Drug Conjugates
Contract Manufacturing
Manufacturing

Date founded

2013

Funding rounds raised

Total raised

$71M

from 9 investors over 9 rounds

M

MabPlex International Co., Ltd. raised $71M on June 8, 2020

Investors: Acusea/Huiyuan Capital, OrbiMed Advisors and Sunshine Insurance Group

M

MabPlex International Co., Ltd. raised $59M on January 17, 2019

Investors: Apollomics, ANTAGENE, 深圳裕策生物科技有限公司, 澳斯康生物制药Thousand Oaks Biopharmaceuticals, Shenzhen Capital Group Co., Ltd and Apic Bio, Inc.

FAQ